Cargando…
EP3 Receptor Deficiency Improves Vascular Remodeling and Cognitive Impairment in Cerebral Small Vessel Disease
Aging and hypertension are major risk factors for cerebral small vessel disease (CSVD). Anti-hypertensive therapy has achieved effective; however, incomplete results in treating CSVD, suggesting the need for additional treatments. Targeting abnormal inflammatory responses has become a topic of resea...
Autores principales: | Liu, Na, Tang, Jie, Xue, Yang, Mok, Vincent, Zhang, Miaoyi, Ren, Xue, Wang, Yilong, Fu, Jianhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782563/ https://www.ncbi.nlm.nih.gov/pubmed/35111376 http://dx.doi.org/10.14336/AD.2021.0627 |
Ejemplares similares
-
The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease
por: Tang, Jie, et al.
Publicado: (2022) -
Decreased nocturnal heart rate variability and potentially related brain regions in arteriosclerotic cerebral small vessel disease
por: Zhang, Miaoyi, et al.
Publicado: (2021) -
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management
por: Zanon Zotin, Maria Clara, et al.
Publicado: (2021) -
Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
por: Wang, Tingting, et al.
Publicado: (2021) -
Effect of cerebral small vessel disease on cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis
por: Wan, Huijuan, et al.
Publicado: (2022)